Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)
Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2712 |
Sku # | A2712-1mg*25 |
Pricing | 1mg*25, $5070.00 |